In patients with advanced NSCLC treated with cytotoxic chemotherapy, elevated CRP was independently associated with poor response and worse survival, even after adjusting for age, gender, smoking status, and NSCLC pathological subtype [53]. This evidence concerns the gene CRP and non-small cell lung carcinoma.